Uncategorized

Anti-VEGF Battles: Eylea Overtakes Lucentis in Japan

This entry was posted in Uncategorized on by (updated 1715 days ago)

In fiscal 2015, top selling drug in ophthalmic space in Japan was Eylea (62.7% increase vs. 2014) and it jumped from second place to surpass the former leader Lucentis (19.1% decrease vs. 2014). Still, Lucentis is increasing sales generator for Novartis Japan 3-rd year in a row. Lucentis Sales in […]